SCI Epidemiology and Complications

Condition(s) studied

Investigational drug(s) / intervention(s)

Retrospective data analysis: Patient data regarding age, gender, etiology of spinal cord injury, level of injury, and whether complications develop will be recorded.

Study summary

The aim of this study was to epidemiologically evaluate patients diagnosed with spinal cord injury who were admitted to our clinic over the last five years and, unlike similar studies, to investigate the presence of complications in these patients. The investigators hope that this study will contribute to the literature by raising awareness of spinal cord injury epidemiology and potential complications.

Eligibility

Primary outcome measure(s)

• Average age and gender of patients followed up in our clinic due to spinal cord injury — 1 month
  -Average age and gender of patients followed up in our clinic due to spinal cord injury
• Etiology of injury in patients followed up in our clinic due to spinal cord injury — 1 month
  Etiology of injury in patients followed up in our clinic due to spinal cord injury 1. Traffic accident 2. Fall from a height 3. Sports injuries 4. Disc herniation/post-surgery 5. Non-traumatic causes/Inflammatory causes 6. Other causes
• Stage of injury in patients followed up in our clinic due to spinal cord injury — 1 month
  -Stage of injury in patients followed up in our clinic due to spinal cord injury 1. C1-C8 2. T1-T12 3. L1-S5
• Whether or not complications developed in patients followed up in our clinic due to spinal cord injury — 1 month
  -Whether or not complications developed in patients followed up in our clinic due to spinal cord injury These complications include: Pressure ulcer, Urinary tract infection, Deep vein thrombosis, Joint contracture, Osteoporosis/fracture, Spasticity, Autonomic dysreflexia, Psychological problems, Sexual problems, Charcot joint, Urethral stricture, Post-traumatic syringomyelia, Heterotopic ossification, Other systemic problems (respiratory problems, cardiac problems, gastrointestinal problems, metabolic and endocrine problems).

Trial sites (1)

More Bandırma Onyedi Eylül University trials in Turkey

Other trials for the same condition